Dassault Systemes agreed to buy ArisGlobal, an AI drug development software company backed by Nordic Capital, for up to $2 billion.
Why it matters: ArisGlobal is cashing out at an opportune moment, trading to a deep-pocketed strategic buyer amid mounting competition and a software sell-off.
